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Dorsal root ganglia (DRGs) host the somata of sensory neurons which convey information 
from the periphery to the central nervous system. These neurons have heterogeneous size 
and neurochemistry, and those of small-to-medium size, which play an important role in 
nociception, form two distinct subpopulations based on the presence (peptidergic) or absence 
(non-peptidergic) of transmitter neuropeptides. Few investigations have so far addressed the 
spatial relationship between neurochemically different subpopulations of DRG neurons and 
glia. We used a whole-mount mouse lumbar DRG preparation, confocal microscopy and 
computer-aided 3D analysis, to unveil that IB4+ non-peptidergic neurons form small clusters 
of 4.7 ± 0.26 cells, differently from CGRP+ peptidergic neurons that are, for the most, isolated 
(1.89 ± 0.11 cells). Both subpopulations of neurons are ensheathed by a thin layer of satellite 
glial cells (SGCs) that can be observed after immunolabeling with the specific marker 
glutamine synthetase (GS). Notably, at the ultrastructural level we observed that this glial 
layer was discontinuous, as there were patches of direct contact between the membranes of 
two adjacent IB4+ neurons. 
To test whether this cytoarchitectonic organization was modified in the diabetic neuropathy, 
one of the most devastating sensory pathologies, mice were made diabetic by streptozotocin 
(STZ). In diabetic animals, cluster organization of the IB4+ non-peptidergic neurons was 
maintained, but the neuro-glial relationship was altered, as STZ treatment caused a 
statistically significant increase of GS staining around CGRP+ neurons but a reduction around 
IB4+ neurons. Ultrastructural analysis unveiled that SGC coverage was increased at the 
interface between IB4+ cluster-forming neurons in diabetic mice, with a 50% reduction in the 
points of direct contacts between cells. These observations demonstrate the existence of a 
structural plasticity of the DRG cytoarchitecture in response to STZ. 
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Except for certain specialized receptors, the cell bodies of the primary sensory neurons are 
grouped in a series of ganglia of the peripheral nervous system associated to the brain or the 
spinal cord. In the latter they are situated along the dorsal roots of the spinal nerves and 
commonly referred to as dorsal root ganglia (DRGs). DRGs are made of pseudounipolar 
neurons and the surrounding glia. Neurons may be simply classified into small-to-medium 
sized cells, mostly specialized in encoding noxious stimuli, and medium-to-large sized cells, 
typically encoding innocuous low-threshold stimuli (Lawson & Waddell, 1991; Lawson, 
2002). However, these two populations are highly heterogeneous, and small-to-medium sized 
DRG neurons may be further subdivided into peptidergic or non-peptidergic cells. Peptidergic 
neurons are about 30-45% of the total number of DRG neurons, and typically express one or 
more neuropeptides among which the more common is the calcitonin gene-related peptide 
(CGRP) (Gibson et al., 1984; Lawson, 1995), which is now accepted as the best marker to 
identify these cells. Non-peptidergic neurons, representing another third of the total 
population of DRG neurons, are of smaller size and, at least in mouse, can be specifically 
identified after histochemical labeling with the isolectin B4 (IB4) from Griffonia simplicifolia 
(Silverman and Kruger, 1990). 
Irrespective of their neurochemical heterogeneity, neurons are generally believed to be 
evenly distributed within ganglia, and only few studies have probed this view by appropriate 
anatomical investigations (Burton & McFarlane, 1973; Wessels et al., 1990; Puigdellívol-
Sánchez et al., 1998; Yan et al., 2002; Ostrowski et al., 2017). Again disregarding their 
heterogeneity, the cell bodies of the DRG neurons are individually enwrapped by satellite glial 
cells (SGCs), so that each neuron forms a discrete unit, sharply separated anatomically and 
insulated electrically from the adjacent nerve cells (Pannese, 2010). 
Still, the neurochemical diversity of the DRG neurons is very important, because it 
underscores their functional diversification, particularly regarding the intervention in the 
initial processing of nociceptive stimuli (see Merighi, 2018). Remarkably, whereas many 
studies have demonstrated that SGCs go through important functional alterations in pain, 
specifically in the diabetic neuropathy (Hanani et al., 2014; Verkhratsky & Fernyhough, 2014), 
as well as in the presence of sustained visceral pain (Huang et al., 2010), no data are available 
as regarding the possibility that the DRG neurons undergo structural plasticity when pain 
processing is altered or disturbed. 
To provide further information about the neuron-to-glia structural association in mouse 
DRGs, as well as on its putative plasticity in the diabetic neuropathy, we here used confocal 
microscopy coupled with 3D computer-aided analysis in a whole-mount ganglion preparation 
(Ciglieri et al., 2016) and transmission electron microscopy (TEM) to study the tridimensional 
organization of CGRP+ and IB4+ DRG neurons, as well as their SGCs in normal and diabetic 
mice. Diabetes was induced by a single high dose injection of streptozotocin (STZ). STZ has a 
structural similarity with glucose and is taken up by pancreatic β cells via glucose transporter 
2, causing the death of the cells by DNA fragmentation and impairment of glucose transport 
(Ventura-Sobrevilla et al., 2011). This model induces a severe and long lasting neuropathy, 
characterized by variable alterations of sensory profiles (Ventura-Sobrevilla et al., 2011).  
Together, our results showed that the IB4+ non-peptidergic neurons were organized in small 
clusters, while the CGRP+ peptidergic neurons were evenly scattered across the DRGs. While 
this organization remained unaltered in diabetic mice, the SGCs surrounding the two 
populations of DRG neurons were subjected to extensive structural alterations that may be a 
histological substrate at the basis of nociceptive alterations in diabetes. 
Methods  
Animals 
All experimental procedures were approved by the Italian Ministry of Health and the 
Committee of Bioethics and Animal Welfare of the University of Torino (417/2016-PR). 
Animals were maintained according to the NIH Guide for the Care and Use of Laboratory 
Animals and to current EU and Italian regulations. 
Male CD1 mice (20-30 g) were housed in a controlled environment and maintained on a 
12/12-hour light/dark cycle with food and water ad libitum. All experiments were performed 
in both control (normoglycemic) and diabetic (hyperglycemic) mice. To induce diabetes, 
animals at postnatal day 30 (P30) received one single intraperitoneal injection of 
streptozotocin (STZ - Sigma, St. Louis, MO, USA, Cat# S0130). STZ was administered at a dose 
of 150 mg/kg freshly dissolved in 0.1 M citrate buffer pH 4.5 to experimental animals, 
whereas control mice only received the vehicle. Four weeks later (P60), following tail 
venipuncture in 5 hour-fasted animals, glycemia was measured using a glucose oxidase 
impregnated test strip (Glucocard sensor; Menarini, Firenze, Italy). Only mice with a blood 
glucose concentration higher than 300 mg/dL were considered diabetic and used for the 
subsequent experiments (see Fig. S1). 
 
Whole-mount DRG preparation 
Immunofluorescence experiments were performed on a whole-mount lumbar DRG 
preparation, as previously described (Ciglieri et al., 2016). Briefly, mice (control N=41, 
diabetic N=31) were anesthetized with a lethal dose of sodium pentobarbital (30 mg/kg, 
intraperitoneal). Dissection of the lumbar DRGs was then performed by constantly 
maintaining tissues in an ice-cold cutting solution, containing: sucrose 252 mM, KCl 2.5 mM, 
NaHCO3 26 mM, NaH2PO4 1.25 mM, D-glucose 10 mM, kynurenate 1 mM, MgCl2 3 mM, CaCl2 
1.5 mM, saturated with 95% O2-5% CO2. DRGs were removed after cutting the vertebral 
column along the midline; then, they were incubated for 1 hour at 37°C in constantly 
oxygenated artificial cerebro-spinal fluid (aCSF), containing: NaCl 126 mM, KCl 2.5 mM, D-
glucose 10 mM, NaHCO3 26 mM, NaH2PO4 1.25 mM, CaCl2 2mM, MgCl2 1.5 mM and collagenase 
(7 mg/mL, collagenase type 3; Worthington, NJ, USA, Cat#  LS004180) to digest the outer 
connective capsule of the ganglia and to allow for better penetration of the immunoreactants 
for 3D analysis. 
Immunofluorescence 
Acutely dissected, collagenase-treated DRGs were fixed for 30 min with 4% 
paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4), washed several times in phosphate 
buffered saline (PBS; 0.02 M, pH 7.4), and then processed for immunofluorescence as follows: 
i- They were pre-incubated in PBS containing 6% bovine serum albumin for 1 h, followed by 
overnight incubation at 4°C with an IB4 biotin-conjugate (1:250; Sigma, Cat# L2140), washed 
in PBS and incubated for 1 h with Extravidin-FITC (1:500; Sigma, Cat# E276); 
ii- They were pre-incubated in 1% normal goat serum and 0.1% Triton X-100 for 1 h, and then 
incubated overnight at 4°C with the following primary antibodies: polyclonal rabbit anti-CGRP 
antibody (1:500; Sigma, Cat# C8198; Salio & Ferrini, 2016); monoclonal mouse anti-glutamine 
synthetase (GS) antibody, clone GS-6 which specifically stains SGCs (1:50; Merck, Cat# 
MAB302; Magni et al., 2015; Rajasekhar et al., 2015). After washing in PBS, DRGs were 
incubated for 1 h with appropriate secondary antibodies (1:1000; anti-rabbit Alexa Fluor 633- 
Cat# A-21070, anti-rabbit Alexa Fluor 594-Cat# A-11012, anti-mouse Alexa Fluor 546-Cat# 
A-11003; Thermo Fisher, Waltham, MA, USA).  
Negative controls performed by omitting the primary antibodies completely abolished the 
specific staining. 
In a subset of experiments, ganglia were stained with 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI; Sigma, Cat# D9542) by a pre-incubation in PBS containing 0.1% 
Triton X-100 for 30 min followed by 15 min in 300 nM DAPI. 
To obtain Z-series reconstructions, immunostained DRGs were transferred on slides modified 
ad hoc to maintain their 3D volume (Ciglieri et al., 2016) and mounted with Vectashield 
medium (Vector Labs, Burlingame, CA, USA, Cat# H-1000). Immunofluorescence was acquired 
using a confocal microscope (TCS SP5; Leica Microsystems, Wetzlar, Germany) with a 20x 
objective (N.A. 0.17). DAPI was excited with a 405 nm diode laser, FITC with a 488 nm argon 
laser, Alexa Fluor 546 and 594 with a 547 nm HeNe laser and Alexa Fluor 633 with a 633 nm 
HeNe laser. Pinhole was kept at 1 airy unit. Gain and offset were initially set for each 
fluorophore and maintained constant in the subsequent acquisitions. Confocal optical sections 
were taken at 3.5 µm intervals along the Z axis in sequential mode. 
 
Electron microscopy 
Eighteen DRGs (3 DRGs/mouse from three control and three diabetic mice) dissected out 
from mice euthanized as previously described, were fixed in 1% paraformaldehyde + 2% 
glutaraldehyde in PB (0.1 M, pH7.4) overnight at 4°C. After washing in PB, they were post-
fixed in osmium ferrocyanide (1 volume of 2% aqueous osmium tetroxide : 1 volume of 3% 
potassium ferrocyanide) for 1 h at 4°C, dehydrated for 15 min in increasing concentrations of 
acetone (30%, 60%, 90%, 100%), progressively infiltrated with Spurr resin (Electron 
Microscopy Sciences, Hatfield, PA, USA; Cat#14300; data from manufacturer) and embedded 
in 0.5 mL Eppendorf tubes (24 h at 70°C). 
Ultrathin sections (80 nm thickness) were cut with an ultramicrotome (EM UC6; Leica), 
collected on uncoated nickel grids (200 mesh) and immunostained following a classical post-
embedding protocol. Sections were treated for 1 min with a saturated aqueous solution of 
sodium metaperiodate, rinsed in 1% Triton X-100 in Tris-buffered saline (TBS; 0.5 M), and 
then incubated for 1 h in 6% bovine serum albumin in TBS. Grids were then transferred 
overnight on drops of the IB4 biotin-conjugate (1:20, Sigma, Cat# L2140). After rinsing in TBS, 
they were incubated in streptavidin coupled to 20 nm colloidal gold particles (1:15; BBI 
Solutions, Crumlin, UK, Cat# EM.STP20), transferred into drops of 2.5% glutaraldehyde in 
cacodylate buffer 0.05 M and, finally, washed in distilled water. Sections were counterstained 
10 min with lead citrate before observation with a JEM-1010 transmission electron 
microscope (Jeol, Tokyo, Japan) equipped with a side-mounted CCD camera (Mega View III, 
Olympus Soft Imaging System, Munster, Germany). 
To assess the neuron-glia distribution in the clusters formed by the IB4+ neurons, 
quantitative ultrastructural analysis was performed onto sixty randomly selected clusters 
from control (n=30) and diabetic (n=30) DRGs. To do so, IB4+ clustered neurons were 
photographed at 15,000x magnification by an operator unaware of the experimental group. 
Individual micrographs were collated together with Photoshop CS2 9 (Adobe Systems, San 
Jose, CA, USA) to obtain a single picture of the cluster and then analyzed with the ImageJ 
Software (NIH, Bethesda, USA). Specifically, the length of the plasma membranes’ apposition 
between two IB4+ clustered neurons was measured, and their distance calculated over 10 
equally spaced points. Opposing membranes were considered in “direct contact” when 
intermembrane distances were ≤30-40 nm. This threshold was set assuming that the 
extracellular space is ≤20 nm and each plasma membrane is about 5 nm thick (Faisal et al., 
2005). A contact index was calculated by dividing the number of intermembrane contact 
points with distance ≤40 nm by the length of the neuronal interface. Then, the proportion of 
IB4+ profiles sharing at least one point of contact in control and STZ-treated mice was 
quantified. 
 
Computerized analysis of  neuronal clusterization  
The spatial distribution of neurons in DRGs was analyzed by an in-house developed software 
for automated 3D analysis (3DRG;see Di Cataldo et al., 2016, Supporting Information Data S1 
and Fig. S2). Analysis was performed on confocal images of the immunostained DRGs to detect 
the peptidergic (CGRP+) and non-peptidergic (IB4+) neuronal populations. 
 
Analysis of SGCs after immunofluorescence stain ing 
The relationship between SGCs and CGRP+/IB4+ neurons was investigated by 1) counting the 
SGCs surrounding each neurochemically identified neuron, 2) measuring the fluorescence 
intensity associated with the SGC marker GS around each identified neuron. 
1) The number of SGCs per sensory neuron was estimated by counting the number of DAPI 
stained nuclei surrounding the equatorial optical section of the neuron, i.e. the largest section 
on the z-axis. The number of nuclei was normalized to the cross-sectional area to correct for 
differences in neuronal size. 
2) GS fluorescence intensity was measured at the equatorial optical section (see Fig. 3C). To 
obtain an unbiased estimate of GS distribution around each neuronal cell body, GS 
fluorescence intensity was measured by the ImageJ Software (https://imagej.nih.gov/ij/) 
along four lines passing through the optical section center and crossing its membrane at 8 
equally spaced points. Since GS staining was concentrated around the neuronal membrane, 
eight peaks of GS fluorescence were detected. GS fluorescence intensity was measured at each 
peak (obtained by averaging three consecutive pixels around the peak; pixel size =1.3 µm) 
and normalized to the background value (measured at the center of the neuronal cell body). 
For each identified neuron, the maximum, minimum and mean GS fluorescence was obtained 
in order to estimate both the fluorescence intensity of SGC marker and its distribution around 
the sensory neurons (see Fig. 3C). 
 
Statistics 
Statistical analysis was performed with GraphPad Prism 7. Differences were evaluated by 
using t-test for independent samples, two-way ANOVA or Mann-Whitney test where 
appropriate. All data were reported as mean ±SEM, with n indicating the number of cells. 




IB4+ non-peptidergic, but not CGRP+ peptidergic neurons are organized in 
small  clusters  
After analysis with the 3DRG software on 147 DRGs obtained from 29 control and 23 diabetic 
mice, CGRP+ neurons resulted to be randomly scattered across the entire ganglion volume 
(Fig. 1A), whereas IB4+ neurons were grouped in clusters (Fig. 1B). Each cluster of IB4+ 
neurons was composed of a mean of 4.7±0.26 cells (Fig. 1C). CGRP+ cells were found in 
clusters that were made of  1.89±0.11 cells. The difference between the number of 
neurons/cluster between the two subpopulations of DRG cells was statistically significant (t-
test, P<0.001; Fig. 1C). There were no numerical alterations in the number of cells/cluster 
when the DRGs from diabetic mice were compared to control mice (Fig. 1C). 
 
The number of SGCs is higher around CGRP+ than IB4+ neurons  
After nuclear staining with DAPI (Fig. 2A-D), the number of SGC nuclei surrounding IB4+ and 
CGRP+ neurons were calculated and statistically analyzed (Fig. 2E). Artifacts due to the 
difference in size of the two subpopulations of sensory neurons were minimized by 
normalizing the number of SGC nuclei to the major cross-sectional area of the neurons 
themselves. Higher numbers of glial cells nuclei/area were consistently observed around 
CGRP+ neurons as compared to IB4+ neurons. In controls, SGCs nuclei were 12±0.4*10-3/µm2 
around CGRP+ neurons (n=80), while they were 7±0.4*10-3/µm2 around IB4+ neurons (n=70; 
t-test, P<0.001). Similarly, in diabetic mice SGCs nuclei were 12±1*10-3/µm2 around CGRP+ 
neurons (n=40), while they were 7±1*10-3/µm2 around IB4+ neurons (n=30; t-test, P<0.001). 
After two-way ANOVA, the differences in the number of SGCs surrounding the two identified 
populations of nociceptors resulted to depend on the cell phenotype but unaffected by the STZ 
treatment (two-way ANOVA, effect of treatment: F (1, 216) = 0.02, P = 0.89; effect of the cell 
phenotype: F (1, 216) = 84.89, P<0.001; treatment factor-interaction between factors: F (1, 
216) = 0.48, P = 0.16 Fig. 2D). 
 
The SGC marker glutamine synthetase (GS) is  differentially affected by 
diabetes according to the cell phenotype.  
The distribution of SGCs around CGRP+ and IB4+ sensory neurons was analyzed indirectly, by 
measuring GS immunofluorescence (Fig. 3A-C). 
Under control conditions, mean GS staining was more intense around IB4+ neurons than 
CGRP+ neurons (Fig. 3D, t-test, P = 0.03). Conversely, both minimal and mean fluorescence 
intensities were higher around CGRP+ neurons than IB4+ neurons in diabetic mice (Fig. 3E, t-
test, P = 0.02 and 0.03). The two-way ANOVA analysis demonstrated a significant interaction 
between treatment and cell phenotype per each level of fluorescence intensity analyzed (Fig 
3F, minimal fluorescence, F (1, 218) = 9.49, P = 0.002; Fig. 3G, mean fluorescence, F (1, 218) = 
9.26, P = 0.003; Fig. 3H, maximal fluorescence, F (1, 218) = 6.13, P = 0.01). Specifically, STZ 
treatment induced a significant decrease of minimal and mean fluorescence intensity around 
IB4+ neurons (minimal fluorescence intensity, t-test, P = 0.001, Fig. 3F; mean fluorescence 
intensity, t-test, P = 0.005, Fig. 3G) and a significant increase of the maximal GS 
immunofluorescence intensity around CGRP+ neurons (t test P=0.048, Fig. 3H). Altogether, 
STZ treatment induced an overall reduction of the  glial layer around IB4 neurons, as 
detectable by GS staining, while causing a hypertrophic reaction around CGRP neurons. 
 
Ultrastructural analysis demonstrates a reduction in the juxtaposition of the 
cell membranes of clustered IB4+ DRG neurons under diabetic conditions  
The presence of glia around the DRG neurons can be easily recognized without specific labels 
as previously described by Pannese (1981, 2010, Fig. 4A-D). In individual ultrathin sections, 
IB4+ clusters consisted of two-three cells and the occurrence of clusters was confirmed in 
both control (Fig. 5A) and diabetic animals (Fig. 5B). In controls, the SGC sheet became 
progressively thinner at the interface between the IB4+ neurons of the same cluster and, in 
some points, the membrane of two opposing neurons appeared in direct contact (Fig. 5C). 
After quantitative analysis, the contact index between cluster-forming IB4+ neurons was 
markedly reduced in diabetic animals (Mann-Whitney test, P<0.01, Fig. 5D, E). Similarly, the 
proportion of neuronal interface exhibiting at least one point of direct contact was reduced of 
about 50% in these mice (Fisher exact test, P<0.05, Fig. 5F). 
 
Results are graphically summarized in Figure 6. 
 
Discussion 
In the present study, we found that the non-peptidergic IB4+ neurons in DRGs form small 
clusters, differently from the CGRP+ peptidergic neurons. This configuration is unaltered in 
diabetic mice.  However, hyperglycemic conditions deeply affect the neuron-glia structural 
relationship between cluster-forming neurons, thus suggesting that the 3D organization of 
these cells has a functional impact. 
 
Structural relationship between sensory neurons and SGCs in DRGs 
It is widely accepted that there are no chemical synapses between the DRG neurons. Yet 
several forms of neuron-to-neuron and neuron-to-glia communication occur in DRGs 
particularly under conditions of inflammation and/or pain. Thus, electrical synapses (gap 
junctions) between DRG neurons are rare under basal conditions (Ledda et al 2009), but their 
number may increase together with neuron-to-neuron dye coupling in experimental 
inflammation (Ledda et al., 2009; Huang et al. 2010). Noteworthy, it was also demonstrated 
that coupled activation of DRG neurons was mediated by an injury-induced upregulation of 
gap junctions in SGCs and that neuronal coupling contributed to pain hypersensitivity (Kim et 
al., 2016). Then, very recently, the gas messenger nitric oxide (NO) released by the DRG 
neurons was shown to induce activation of SGCs and to increase gap-junctional 
communication in vitro (Belzer and Hanani, 2019). Therefore, despite that adult DRG neurons 
are insulated by a non-conductive glial layer, which minimizes their direct interactions (Ohara 
et al., 2009), SGCs intervene in regulating neuronal excitability in DRGs. Mono/bidirectional 
gap junction-mediated neurotransmission between the DRG neurons and the SGCs may not be 
the only type of communication between these cells. Namely, other authors have described 
the occurrence of “sandwich synapses” between the DRG neurons and glia (Rozanski et al., 
2013). Structurally, the sandwich synapses described by Rozanski and colleagues consist of 
neuron–glial cell–neuron trimers, in which membranes are closely apposed in the absence of 
any ultrastructural differentiation if not a narrowing of intermembrane clefts. These authors 
have shown an unidirectional ionic current following through sandwich synapses whereby a 
DRG “cis” neuron forms a first synapse with the SGC that, in turn, forms a second synapse with 
an adjacent “trans” neuron (see Figure 6 in Rozanski et al., 2013). According to the original 
sandwich synapse hypothesis, stimulation in a given “cis” neuron propagates to neighboring 
nerve cells following the activation of the purinergic P2Y12 receptors expressed by the 
surrounding SGCs, which have been hypothesized to release glutamate that acts onto the 
NMDA receptors expressed at the membrane of the “trans” neuron (Rozanski et al., 2013). In 
line with such a possibility, astrocytic glutamate was shown to evoke NMDA receptor-
mediated slow depolarizing inward currents in neurons (Gomez-Gonzalo et al., 2018). In 
DRGs, the spread of excitation driven through sandwich synapses is enhanced in a variety of 
pathological pain conditions (Ohara et al., 2009; Wu et al., 2012; Kim et al., 2016). These 
observations highlight the importance of the spatial contacts among the DRG neurons and 
between them and the SGCs to support their electrical coupling. In line with this, we here have 
demonstrated that the IB4+ non-peptidergic nociceptors were organized in small clusters, 
differently from their CGRP+ peptidergic counterpart. Interestingly, these two subpopulations 
of DRG neurons also displayed a different association with their surrounding glia. Specifically, 
IB4+ neurons exhibited a lower number of associated SGCs, and their membranes were 
directly juxtaposed within the clusters at TEM observation. That glial coverage was 
incomplete led us to speculate that direct neuron-to-neuron communication could occur. 
Direct neuronal appositions, in the absence of synaptic specializations, were previously 
observed between neurochemically unclassified sensory neurons of several species, including 
lizards (Pannese, 2010), chicks (Rozanski et al., 2012), rats (Pannese, 2010) and rabbits (Khan 
et al., 2009). Such a structural arrangement is consistent with their functional coupling by 
mechanisms others than electrical (gap junctions) or sandwich synapses. In their seminal 
study, Devor & Wall (1990) were the first to find that about 5% of DRG neurons induced 
subthreshold activity in the neighboring nerve cells. Later, slow chemical transmission 
between DRG neurons somata was demonstrated to take place with the intervention of ATP 
as a neurotransmitter in chick DRG neurons (Rozanski et al., 2012). In line with these 
observations, we here identify the contact points between IB4+ neurons as a structural 
substrate for electrotonic neuronal coupling. 
 
STZ-induced alterations in the neuron to glia association  
Alterations in SGCs function and in their anatomical relationship with sensory neurons 
strongly affect the spread of excitability across DRGs. SGCs were reported to undergo 
important changes in their morphology and activity, often described as an activated state, that 
contributes to pathological pain and favors pathological pain behavior (Hanani, 2012). In 
addition, direct coupling among clusters of 2-5 DRG neurons, particularly the smaller ones 
(<20 µm), was elegantly demonstrated by in vivo calcium imaging in mice with pathological 
pain (Kim et al., 2016). SGCs activation also occurred in animals where the diabetic 
neuropathy was experimentally induced (Hanani et al., 2014; Jia et al., 2018). As early as two 
weeks after STZ injection, Hanani and coll. (2014) found a significant increase in the 
expression of the glial fibrillary acidic protein (GFAP) in mouse and rat activated SGCs. SGC 
activation was also characterized by an increased expression of P2Y12 receptors, which 
participate to the sandwich synapse mechanism, and connexin 43, which promotes transglial 
spread of excitation through the gap junctions (Jia et al., 2018). 
Very recently Jia and coll. (2018) found that, in diabetic animals, SGCs activation was 
preferentially detected at the level of the CGRP-expressing neurons. Our confocal data from 
STZ-induced diabetic mice support these observations at CGRP neurons; contrariwise, we 
found a decrease of GS staining around IB4+. However, our ultrastructural study unveiled that 
this reduction in GS staining was not associated to a reduction of glia ensheathment, which 
increased at interface between IB4+ cluster-forming neurons.  
This apparently contradictory finding indicates that the mere immunocytochemical analysis 
of glia at the confocal microscopy may not be sensitive enough to detect changes in the SGC 
morphology at nanometric scale. Indeed, within neuronal clusters, glial processes separated 
the neuronal membranes of few tens of nanometers (Faisal et al., 2005) whose fine alterations 
may unlikely to be detected at the light microscopy level. Our data indicate that diabetes 
induced an overall increase in glial coverage at both peptidergic and non-peptidergic neurons 
in DRGs: at the micrometric level in the former and at the nanometric level in the latter. At 
neuronal cluster level, diabetes induces a shift from a condition in which IB4+ neurons share 
extensive contact areas, to a condition in which interneuronal responses might be mediated 
by the interposing SGCs. Importantly, none of the observed changes in glia distribution 
around sensory neurons can be explained in terms of change in SGC number, as we were 
unable to demonstrate any significant change in the number of SGC nuclei in diabetic mice. An 
interesting result of our study is that we have also observed the presence of some gap 
junctions between the DRG neurons and the SGCs in both normal and diabetic DRGs. Several 
papers (quoted above) have in fact demonstrated that neuro-glia gap junctions were the 
structural and functional substrate to explain the activation of the SGCs that occurs in 
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Figure legends 
Fig. 1 Cluster analysis of CGRP+ and IB4+ neurons in DRGs from control and diabetic mice. 
Representative pictures of CGRP+ (A) and IB4+ (B) neurons in DRGs from CTR. The 
enlargements below illustrate the diameters of representative CGRP+ and IB4+ cells. (C) 
Histogram showing the number of cells per cluster of CGRP+ and IB4+ neurons in vehicle-
treated (IB4+ N=48; CGRP, N=58; t-test, P<0.001) and STZ-treated mice (IB4+ N=57; CGRP, 
N=56; t-test, P<0.001). Abbreviations: IB4: isolectin B4; CGRP: calcitonin gene-related peptide; 
CTR: vehicle-treated mice; STZ: streptozotocin-treated mice. ****P < 0.0001. 
Fig. 2 Analysis of the changes in the number of SGCs induced by STZ. (A-D) Representative 
pictures of CGRP (blue), IB4 (green) and DAPI (white) staining on whole-mount DRGs. (E) 
Histograms illustrating the number of DAPI+ nuclei surrounding CGRP+ or IB4+ sensory 
neurons normalized to the cross-sectional area in vehicle- and STZ- treated mice. Two-way 
ANOVA: effect of treatment: F (1, 216) = 0.02, P = 0.89; effect of the cell phenotype: F (1, 216) 
= 84.89, P<0.001; interaction between treatment and phenotype: F (1, 216) = 0.48, P = 0.16. T-
Test: IB4-CTR vs CGRP-CTR, IB4-CTR vs CGRP-STZ, IB4-STZ vs CGRP-CTR, IB4-STZ vs CGRP-
STZ, P<0.001; IB4-CTR vs IB4-STZ, CGRP-CTR vs CGRP-STZ, P > 0.05). Abbreviations: IB4: 
isolectin B4; CGRP: calcitonin gene-related peptide; DAPI, 4′,6-diamidino-2-phenylindole; 
CTR: vehicle-treated mice; STZ: streptozotocin-treated mice. ****P < 0.0001. 
Fig. 3 GS immunostaining and analysis of SGC coverage of CGRP+ and IB4+ neurons. (A-B) 
Representative images showing double staining for the SGC marker GS (red), the peptidergic 
DRG neuron marker CGRP (blue, A), and the non-peptidergic DRG neuron marker IB4 (green, B) 
in vehicle-treated and STZ-treated mice. (C) Method for GS staining analysis. On the left, 
representative single optical section of GS staining around a DRG neuron. Fluorescence 
intensity is measured along the four colored lines, which cross the ensheathing SGC in 8-points 
(white dots) around the DRG neuron. Quantification of the fluorescence intensity along each 
colored line is illustrated in the graph on the right, using the same color code. GS fluorescence 
intensity is measured at the white dots, i.e. the peaks in the graphs, and then normalized to 
internal background (yellow dot). (D) Minimal, mean and maximal GS fluorescence intensities 
around CGRP+ or IB4+ neurons vehicle-treated mice. T-test: Min, P = 0.053; Mean, P = 0.028; 
Max, P = 0.079. (E) Minimal, mean and maximal GS fluorescence intensities around CGRP+ or 
IB4+ neurons in STZ-treated mice. T-test: Min, P = 0.016; Mean, P = 0.028; Max, P = 0.056. (F) 
Dot plot graph of minimal GS fluorescence intensity. Two-way ANOVA: interaction between 
treatment and phenotype: F (1, 218) = 9.49, P = 0.002; effect of treatment: F (1, 218) = 2.99, P = 
0.085; effect of the cell phenotype: F (1, 218) = 0.02, P = 0.88. IB4-CTR vs IB4-STZ, t-test, P = 
0.0014; CGRP-CTR vs CGRP-STZ, t-test, P = 0.32. (G) Dot plot graph of mean GS fluorescence 
intensity. Two-way ANOVA: interaction between treatment and phenotype: F (1, 218) = 9.26, P 
= 0.003; effect of treatment: F (1, 218) = 8.45, P = 0.36; effect of the cell phenotype: F (1, 218) = 
0.015, P = 0.9. IB4-CTR vs IB4-STZ, t-test, P = 0.005; CGRP-CTR vs CGRP-STZ, t-test, P = 0.14. 
(H) Dot plot graph of maximal GS fluorescence intensity. Two-way ANOVA: interaction between 
treatment and phenotype: F (1, 218) = 6.12, P = 0.014; effect of treatment: F (1, 218) = 0.17, P = 
0.68; effect of the cell phenotype: F (1, 218) = 0.017, P = 0.69. IB4-CTR vs IB4-STZ, t-test, P = 
0.13; CGRP-CTR vs CGRP-STZ, t-test, P = 0.048. Abbreviations: IB4: isolectin B4; CGRP: 
calcitonin gene-related peptide; CTR: vehicle-treated mice; STZ: streptozotocin-treated mice; 
GS: glutamine synthetase. *P < 0.05, **P < 0.01.  
Fig. 4 Ultrastructure of the DRG neurons in control mice. (A) An ensheathing layer made of 
SGC processes (arrowheads) separates two adjacent neurons. (B) The neuronal membranes of 
two adjacent neurons are in direct contact (arrows), without SGC interposition. (C) High-
magnification of panel A. Note the presence of an SGC process between the sensory neuron 
somata (arrowheads) and gap-junctions between neuron and SGC (red double arrowheads). (D) 
High magnification of panel B. Note the lack of SGC interposition between the facing 
membranes of the two neurons (arrows). Abbreviation: SGC: Satellite glial cell; N: nucleus; ct: 
connective tissue.  
Fig. 5 Ultrastructural analysis of IB4+ DRG neurons in control and diabetic mice. (A) In CTR, 
the membranes of two adjacent clustered IB4+ sensory neurons are juxtaposed, without the 
interposition of glia (arrowheads). (B) In STZ-treated mice, a glial sheath is present between 
two IB4+ neurons of the same cluster (arrows). (C) High magnification of panel A. Note the 
occurrence of 20 nm gold particles indicative of IB4 immunogold staining scattered over the 
entire length of the juxtaposed neuronal membranes (arrowheads). (D) High-magnification of 
panel B. Note the glia separating the membranes of two IB4+ DRG neurons (arrows) and a gap-
junction between the neuron and SGC (red double arrowheads). (E) Contact index in vehicle-
treated mice and STZ-treated mice. The contact index is markedly reduced in STZ (Mann-
Whitney test, P<0.01). (F) Pie charts showing the proportion of neuronal membranes 
exhibiting at least one point of contact (Fisher exact test, P<0.05) in CTR and STZ-treated mice. 
Abbreviation: SGC: Satellite glial cell; N: nucleus; CTR: vehicle-treated mice; STZ: 
streptozotocin-treated mice. 
Fig. 6 Schematic summary of neuro-glia relationship in DRGs of control and diabetic mice. (A) 
Representation of a simplified dorsal root ganglion (DRG) in control (CTR) mice: IB4+ 
neurons (green) are grouped in cluster and surrounded by a few satellite glial cells (SGC). 
SGCs form a continuous glutamine synthetase (GS)+ sheet around neurons (red thick line) 
which becomes thinner at the interface of two IB4+ opposing neurons. At some points, the 
membranes of cluster-forming IB4+ neurons are in direct contact (yellow arrowheads). 
CGRP+ neurons (blue) are randomly scattered across the DRG and surrounded by numerous 
SGCs with relatively less bright GS immunostaining (red thin line). (B) In streptozotocin 
(STZ)-induced diabetic mice, IB4+ neurons (green) are still grouped in clusters and CGRP+ 
neurons (blue) randomly scattered across the DRG. However, GS fluorescence intensity is 
higher around CGRP+ neurons (red thick line) than in IB4+ neurons (red thin line). Moreover, 




Additional Supporting Information may be found in the online version of this article: 
Data S1 Computerized analysis of neuronal clusterization .  
Fig. S1 Blood glucose concentration in control and diabetic mice. 
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